Contact this trialFirst, we need to learn more about you.
Sphingosine-1-phosphate receptor modulator
Ozanimod for Multiple Sclerosis
Recruiting3 awardsPhase 4
Aurora, Colorado
"This trial aims to see if ozanimod is safe and effective as a treatment for multiple sclerosis patients who have already been treated with anti-CD20 therapy and are currently stable."
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service